Oragenics Stock Price

-0.1395 (-15.17%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Oragenics Inc OGEN AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.1395 -15.17% 0.7801 19:58:49
Open Price Low Price High Price Close Price Prev Close
0.878 0.77 0.9078 0.7956 0.9196
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
19,241 8,757,050 $ 0.8247469 $ 7,222,350 33,768,904 0.26 - 2.12
Last Trade Time Type Quantity Stock Price Currency
19:59:31 29 $ 0.78 USD

Oragenics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 71.59M 91.77M 80.39M $ - $ - -0.37 -2.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Oragenics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.121.140.771.005,899,015-0.3399-30.35%
1 Month1.011.800.771.3116,895,452-0.2299-22.76%
3 Months0.431.800.410.914192925,410,2060.350181.42%
6 Months0.60931.800.3770.841278914,036,2480.170828.03%
1 Year0.682.120.260.88868259,667,5500.100114.72%
3 Years1.684.200.260.98990184,509,498-0.8999-53.57%
5 Years10.6011.200.261.042,756,134-9.82-92.64%

Oragenics Description

Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and have other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.